atazanavir sulfate has been researched along with Gallstone Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gatanaga, H; Hamada, Y; Kikuchi, Y; Komatsu, H; Nishijima, T; Oka, S; Teruya, K | 1 |
| Gatanaga, H; Hamada, Y; Kikuchi, Y; Komatsu, H; Nishijima, T; Oka, S; Shimbo, T | 1 |
| Arvieux, C; Borsa-Lebas, F; de la Blanchardière, A; Giroux, F; Hue, G; Jantzem, H; Kerspern, H; Massy, N; Meskar, A; Michau, C; Poinsignon, Y; Polard, E; Rakotondravelo, S; Tattevin, P; Tribut, O | 1 |
3 other study(ies) available for atazanavir sulfate and Gallstone Disease
| Article | Year |
|---|---|
Is ritonavir-boosted atazanavir a risk for cholelithiasis compared to other protease inhibitors?
Topics: Adult; Atazanavir Sulfate; Cholelithiasis; Female; HIV Infections; HIV Protease Inhibitors; Humans; Male; Middle Aged; Oligopeptides; Pyridines; Retrospective Studies; Ritonavir | 2013 |
Cumulative exposure to ritonavir-boosted atazanavir is associated with cholelithiasis in patients with HIV-1 infection.
Topics: Abdomen; Adult; Anti-HIV Agents; Atazanavir Sulfate; Cholelithiasis; Cross-Sectional Studies; Female; HIV Infections; HIV-1; Humans; Male; Oligopeptides; Prevalence; Pyridines; Ritonavir; Time Factors; Ultrasonography | 2014 |
Complicated atazanavir-associated cholelithiasis: a report of 14 cases.
Topics: Adult; Aged; Aged, 80 and over; Anti-HIV Agents; Atazanavir Sulfate; Calculi; Cholelithiasis; Female; HIV Infections; Humans; Male; Middle Aged; Oligopeptides; Pyridines; Spectrophotometry, Infrared | 2012 |